Spectral Medical Inc T.EDT

Low Share Price Because...

[Accountprince]

Hit $0.255 per share this morning.  This is very low for a share that is in a confirmatory trial and has completed 61 of 90 patients (interim point and 60% of total confirmatory trial) and is EXCEEDING EXPECTATIONS.  Further, Baxter is on the sidelines and made their intentions and commitment to PMX and the EAA absolutely clear.  From the product development perspective things couldn't be much better, the prospects couldn't be higher and the ultimate value of the phase 3b looking like a multi billion dollar success.  For a very serious, large and unmet medical need.  And a product proven effective outside the US where it is approved.

The recent shareholder vote underscores why the share price is low.  Several long standing directors (Bihl, Nosenzo, Seto) very close to a non-confidence vote.  Many others with unusually low support.  A long term incentive plan very close to defeat.  And the carte blanche share consolidation plan shot down by the shareholders.

So the evidence indicates the real problem with the share price is the BOD governance and management.  Based on the nature of the votes a very large shareholder constituency does not trust them to govern appropriately.  There is no other conclusion that can be reached.  Rumor has it that a new financing is underway and the dropping share price seems evidentiary to this rumor.  Who does this dropping share price benefit?  You guessed it...

[hmmmmmmmm]

I'd agree that we are witnessing rookie Seto and an inutile board tank this company in real time. I think they made it abundantly clear to all that their goals are their own- not shareholders. How else do you explaine the self-serving of millions and milions of options- while clearly failing to achieve any of their stated trial goals over the last 3 yrs. Real management would have respected

[Accountprince]

hmmmmmmm...Don't you wish we'd had a real shareholder activist a few months ago?  I did. Won't go any lower than this unless intentionally done.  In any business you can analyze what the liquidation (scrap) value is.  In this case it's a confirmatory 3b trial that's exceeding expectations with 61 of the interim (90 patients) done and the FDA giving fast track

[hmmmmmmmm]

Ha.  I do wish that  a few shareholders that post here didn't believe that by pretending everything was great a real problem would just disappear.  Posters who have spoken out frankly about management in DMs- but instead of being voices for positive change here- thought it was more important to pump up a temporary share price.. Posters who smelt smoke- and would yell "

[Accountprince]

Who's pretending that everything is great?  Did you not see the votes for the AGM?  Many many unhappy Spectral shareholders that voted how they felt.  Who the hell do you think opposed things to the tune of 44% and stopped the carte blanche share consolidation?  Was it you - I hardly think so - hard to raise a voice when you have no shares.  You only come on here and

[BayStreetWild]

You're a dork. First, I didn't write that post. Second.. what do you know about the baxter agreement. It could just as easily be a 2.5 million dollar convertible debenture that would take them another quarter forward as it could be 10 million... we don't know. Second, I was here for 2016 and that exceeding expectations thing means nothing. If it meant something it would be FDA approved

[Accountprince]

I had addressed hmmmmmmm without a mention of BSWild.  Perhaps you are he?  Since you answered in a fit of rage?  You all blend together with the same old blah blah anyway. We all don't know what the Baxter deal has...it was redacted remember?  If you know please share.  But it would be very unusual to pay an initial $5 million and then when a milestone is passed pay

[BayStreetWild]

You said he doesn't own any shares... he said he's heavily invested and unhappy..   im the one that said I hardly own any and am upset about what happened here... clearly you were speaking to me.

[BayStreetWild]

Sure, I can give you my working hypothesis. they redacted the deal but when the last financing was done, I noticed in the press release it made claim that baxter was giving them a portion of the next possible payment now to help move them along. I also noticed it was done as a convertible debenture so that's what makes me think it will be one down the road... it also makes me think it takes

[BayStreetWild]

Is your thinking... they saw the company spent 20 years and  $ 100+ million to get to where they are today (having seen the entire dataset from the last trial) so they said.. oh we will give them $5 million but when they get to interim enrolment and spend another $ 40 million to get there... we will give them $ 20 million?

[BayStreetWild]

The way they're flogging baxters name in every press release leads me to believe it's more about promo than anything else. I don't know what the next payment will be or what this deal looks like but I can tell you they're milking it to the max because without that I'm not sure if they could raise even $1.. and then who would pay the salaries.  also the way they're